Summarized by Masters of Longevity from Longevity Technology.
Retrospective English primary-care data found better glycemic and weight outcomes with tirzepatide.
Key Takeaways
- Tirzepatide was linked to about 1 in 4 losing ≥15% weight.
- Tirzepatide patients achieved HbA1c <6.5% roughly twice as often.
- The study was retrospective and cannot establish causal effects.
